However, our study revealed that the frequency of Glo1 amplification is low (1.0%) in breast cancer (Figure 1B) and that alteration of Glo1 copy number, including gene amplification, did not correlate with poor clinical outcome (Supplementary Figure 1A). This evidence concerns the gene GLO1 and breast cancer.